本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Day One Biopharmaceuticals Inc.

7.90
+0.46006.18%
盤後7.900.00000.00%16:37 EDT
成交量:114.33萬
成交額:876.22萬
市值:8.01億
市盈率:-7.71
高:7.91
開:7.41
低:7.35
收:7.44
資料載入中...
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/11/07

重要事件披露

8-K - Current report
2022/11/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/02

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/10/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/12

重要事件披露

8-K - Current report
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/24

重要事件披露

8-K - Current report
2022/06/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/16

重要事件披露

8-K - Current report
2022/06/13

重要事件披露

8-K - Current report
2022/06/08

SEC問詢函

CORRESP [Cover] - Correspondence